Matches in Wikidata for { <http://www.wikidata.org/entity/Q58596102> ?p ?o ?g. }
- Q58596102 description "artículu científicu espublizáu en payares de 2018" @default.
- Q58596102 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58596102 description "scientific article published on 07 November 2018" @default.
- Q58596102 description "wetenschappelijk artikel" @default.
- Q58596102 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58596102 name "Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer" @default.
- Q58596102 name "Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer" @default.
- Q58596102 type Item @default.
- Q58596102 label "Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer" @default.
- Q58596102 label "Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer" @default.
- Q58596102 prefLabel "Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer" @default.
- Q58596102 prefLabel "Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer" @default.
- Q58596102 P1433 Q58596102-D92F998A-3A3C-465A-818E-15F748CA1AB7 @default.
- Q58596102 P1476 Q58596102-F660B017-CA67-4243-95D9-86E51C6FA2C4 @default.
- Q58596102 P2093 Q58596102-29A1EE42-EF86-4E8C-99EA-AD1A7DCD973D @default.
- Q58596102 P2093 Q58596102-4A092863-3A0F-4478-909A-78A5E5500F24 @default.
- Q58596102 P2093 Q58596102-87D5F501-279C-4286-B1CF-17EDF2C018D6 @default.
- Q58596102 P2093 Q58596102-DB7B5F94-4626-4D0B-9BA5-7D877E987EF5 @default.
- Q58596102 P2093 Q58596102-FED8568F-D929-44A1-8ED9-BB7C4ADB69B4 @default.
- Q58596102 P2860 Q58596102-05C1A0EF-0F64-4E6C-A1B8-217BC5763BE4 @default.
- Q58596102 P2860 Q58596102-0BDD8744-C632-4934-A04E-59E463817DB0 @default.
- Q58596102 P2860 Q58596102-1003D74A-A02A-4BBC-A66E-7857679A8BF1 @default.
- Q58596102 P2860 Q58596102-14356BE1-6CEC-4065-BEA8-97EEDE840D90 @default.
- Q58596102 P2860 Q58596102-17A59621-8E51-4F49-B3EC-E3B1E48AF58F @default.
- Q58596102 P2860 Q58596102-1AAA2A28-EFA2-4BF5-9DCF-CF50237A1050 @default.
- Q58596102 P2860 Q58596102-1CB8D173-9D1F-419D-95F5-3A7702A05631 @default.
- Q58596102 P2860 Q58596102-229E22FC-2368-413F-A674-B447F73E8023 @default.
- Q58596102 P2860 Q58596102-24A3A346-62DA-47F7-B975-23591B780A0F @default.
- Q58596102 P2860 Q58596102-2CB02AFC-0CA6-4266-9064-2E61C679ABA4 @default.
- Q58596102 P2860 Q58596102-2D035056-8C3B-4CB1-B130-87F656D39769 @default.
- Q58596102 P2860 Q58596102-2E6B9840-87FF-4E95-AA26-81A710E30628 @default.
- Q58596102 P2860 Q58596102-3CB1FE99-771C-4F3F-A976-7B4986924037 @default.
- Q58596102 P2860 Q58596102-443816EC-7AE0-45F9-BF5A-DDD76EF62A11 @default.
- Q58596102 P2860 Q58596102-46DBE98E-9059-4800-B6A8-A55F3FE2B972 @default.
- Q58596102 P2860 Q58596102-55FEEFF0-574C-4E92-8616-1EAC0401F47B @default.
- Q58596102 P2860 Q58596102-62452E34-20B4-4635-94B2-9698E4704140 @default.
- Q58596102 P2860 Q58596102-647311C3-3568-46BB-858A-E8AC47D76D45 @default.
- Q58596102 P2860 Q58596102-697A07B5-5998-41EB-BE31-A54971E77AE1 @default.
- Q58596102 P2860 Q58596102-7281563F-26FA-4D51-B69C-E38943DBA9F0 @default.
- Q58596102 P2860 Q58596102-77B425B1-C441-4D32-AB48-4A7985101E7A @default.
- Q58596102 P2860 Q58596102-7852A72B-EC67-4EA7-97BE-EA3E2C147C60 @default.
- Q58596102 P2860 Q58596102-7A6702D4-E769-47B2-8058-F0B754FA14D5 @default.
- Q58596102 P2860 Q58596102-7F079CDE-FA5E-47CC-9FC1-973E2842A24B @default.
- Q58596102 P2860 Q58596102-80B59351-B6A0-4312-A48B-F1D16F74367F @default.
- Q58596102 P2860 Q58596102-8426321E-69BE-4C1D-ACBB-EDB5E540B55A @default.
- Q58596102 P2860 Q58596102-86BBB548-D4B5-4105-8207-F9345DB073D5 @default.
- Q58596102 P2860 Q58596102-8B75F3A8-2BC2-4830-A271-BECD4219FC33 @default.
- Q58596102 P2860 Q58596102-9495FBA1-5FC1-46F9-BBDD-82729D2970BA @default.
- Q58596102 P2860 Q58596102-9B763AF6-8E09-4CC8-A097-5688B6BCEB3B @default.
- Q58596102 P2860 Q58596102-A45063CE-A44F-40A1-885B-AB072CB7CF5E @default.
- Q58596102 P2860 Q58596102-B66F7B13-E732-47E3-9D8A-038C560C172F @default.
- Q58596102 P2860 Q58596102-C5D74BE6-EB89-4CC9-837A-00CE60C5B775 @default.
- Q58596102 P2860 Q58596102-C9C3DDF6-7D79-4FB5-91F6-1DDB0C3B6C42 @default.
- Q58596102 P2860 Q58596102-CEF10F4A-937D-4704-82A5-17F6610C388A @default.
- Q58596102 P2860 Q58596102-D49CBF88-D817-4012-9B35-F50F2B92CA42 @default.
- Q58596102 P2860 Q58596102-D91AB1AB-E405-435E-9802-638E8F835631 @default.
- Q58596102 P2860 Q58596102-DB6AD419-0341-4338-803D-A5267475D1B0 @default.
- Q58596102 P2860 Q58596102-DD975E83-B2C3-4C27-811E-331E0AADEB93 @default.
- Q58596102 P2860 Q58596102-DEBB309D-7532-4D48-A0DD-B9A46EC1E07B @default.
- Q58596102 P2860 Q58596102-E4FAC64C-7BF6-4992-9487-29BF74025B06 @default.
- Q58596102 P2860 Q58596102-E6382868-0F05-4720-AB69-86576260AAEC @default.
- Q58596102 P2860 Q58596102-EA232683-512A-4EF6-9E94-04075880A8DC @default.
- Q58596102 P2860 Q58596102-ECAA0C3B-A01F-4BB0-8445-575DF4E05BE8 @default.
- Q58596102 P2860 Q58596102-ED64C367-5020-4E58-B18B-630D28E7E172 @default.
- Q58596102 P2860 Q58596102-ED9C0E00-F291-4466-B3D0-059DBDB51D4B @default.
- Q58596102 P2860 Q58596102-F1234F12-1EC3-4B1F-898C-EF351BCEF684 @default.
- Q58596102 P2860 Q58596102-FA5D9CDF-EFF9-4BFD-8E04-63A2EC217FD6 @default.
- Q58596102 P304 Q58596102-957492A7-3B05-45F8-B8ED-F69BF2A62200 @default.
- Q58596102 P31 Q58596102-E373FD4B-E1DC-42E8-AD1A-5663ECFB8A86 @default.
- Q58596102 P356 Q58596102-4C591D04-A57B-4390-82FC-618A3DA03610 @default.
- Q58596102 P407 Q58596102-D9191296-00CD-41A0-B17E-875166D5C6BE @default.
- Q58596102 P433 Q58596102-04763176-D1D5-40DB-BA77-E4A4981587AE @default.
- Q58596102 P478 Q58596102-44CB78C1-D720-43A8-BA95-AA767FBF21F4 @default.
- Q58596102 P50 Q58596102-FE20A30F-C869-4D59-8F7A-1880F12208EA @default.
- Q58596102 P577 Q58596102-5B3F3A6A-B8BA-4339-BAFD-321746E26985 @default.
- Q58596102 P698 Q58596102-E38615A2-CC4F-4C84-B5EE-410602F78890 @default.
- Q58596102 P921 Q58596102-3DB49388-9F14-4C4F-9ABE-0498B2579510 @default.
- Q58596102 P921 Q58596102-FC3D24A6-588D-4247-98D9-4EF1F21FC174 @default.
- Q58596102 P356 S10637-018-0687-5 @default.
- Q58596102 P698 30402678 @default.
- Q58596102 P1433 Q2312231 @default.
- Q58596102 P1476 "Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer" @default.
- Q58596102 P2093 "Jorge A Garcia" @default.
- Q58596102 P2093 "Matthew Cooney" @default.
- Q58596102 P2093 "Prateek Mendiratta" @default.
- Q58596102 P2093 "Robert Dreicer" @default.
- Q58596102 P2093 "Ruby Gupta" @default.
- Q58596102 P2860 Q27852197 @default.
- Q58596102 P2860 Q27860904 @default.
- Q58596102 P2860 Q28183621 @default.
- Q58596102 P2860 Q28277365 @default.
- Q58596102 P2860 Q29615536 @default.
- Q58596102 P2860 Q29616123 @default.
- Q58596102 P2860 Q29616218 @default.
- Q58596102 P2860 Q29617472 @default.
- Q58596102 P2860 Q29617511 @default.
- Q58596102 P2860 Q29617512 @default.
- Q58596102 P2860 Q29618608 @default.
- Q58596102 P2860 Q29620155 @default.
- Q58596102 P2860 Q29620676 @default.